Abstract
Thirty-six-month amyloid positron emission tomography results show continued reduction in amyloid burden with gantenerumab (3931)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1212/wnl.94.15_supplement.3931
Journal: Neurology | Publication Date: Apr 14, 2020 |
Thirty-six-month amyloid positron emission tomography results show continued reduction in amyloid burden with gantenerumab (3931)
Join us for a 30 min session where you can share your feedback and ask us any queries you have